StrataMap Spatial meets the growing demand for scalable spatial biology studies from research and biopharma customers, through features such as:

  • Capture area: The 7.5 cm2 capture area accommodates serial sections for researchers to create a multidimensional understanding of tissues. Users can also profile multiple fresh frozen tissue sections of varying sizes and shapes simultaneously. The solution is species-agnostic and accommodates a broad range of eukaryotic tissue samples and tissue RNA quality. Illumina is actively developing an FFPE-specific solution and targets initial customer enablement in 2027.
  • Scale: StrataMap Spatial can process more than 2000 samples per year.
  • Speed: Multiple slides can be run in parallel, with library preparation and sequencing following traditional NGS methods. Sequencing takes as few as 22 hours. Including imaging, sequencing, and analysis, customers can move from sample to insight in less than 5 days.
  • Accessibility: Instead of investing in expensive, specialized systems, customers can integrate StrataMap Spatial into their existing histopathology workflows. StrataMap Spatial then runs on the NovaSeq and NextSeq platforms, giving existing customers an accessible entry point into spatial biology.